Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments
Open Access
- 1 January 2012
- journal article
- Published by Frontiers Media SA in Frontiers in Computational Neuroscience
- Vol. 6, 52
- https://doi.org/10.3389/fncom.2012.00052
Abstract
Several independent studies show that accumulation of β-amyloid (Aβ) peptides, one of the characteristic hallmark of Alzheimer's Disease (AD), can affect normal neuronal activity in different ways. However, in spite of intense experimental work to explain the possible underlying mechanisms of action, a comprehensive and congruent understanding is still lacking. Part of the problem might be the opposite ways in which Aβ have been experimentally found to affect the normal activity of a neuron; for example, making a neuron more excitable (by reducing the A- or DR-type K+ currents) or less excitable (by reducing synaptic transmission and Na+ current). The overall picture is therefore confusing, since the interplay of many mechanisms makes it difficult to link individual experimental findings with the more general problem of understanding the progression of the disease. This is an important issue, especially for the development of new drugs trying to ameliorate the effects of the disease. We addressed these paradoxes through computational models. We first modeled the different stages of AD by progressively modifying the intrinsic membrane and synaptic properties of a realistic model neuron, while accounting for multiple and different experimental findings and by evaluating the contribution of each mechanism to the overall modulation of the cell's excitability. We then tested a number of manipulations of channel and synaptic activation properties that could compensate for the effects of Aβ. The model predicts possible therapeutic treatments in terms of pharmacological manipulations of channels' kinetic and activation properties. The results also suggest how and which mechanisms can be targeted by a drug to restore the original firing conditions.Keywords
This publication has 51 references indexed in Scilit:
- Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept studyJournal of Neural Transmission, 2011
- Computational Models of Neuronal Biophysics and the Characterization of Potential Neuropharmacological TargetsCurrent Medicinal Chemistry, 2008
- Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic MiceNeurodegenerative Diseases, 2008
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007
- Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD MiceJournal of Neuroscience, 2007
- On the Initiation and Propagation of Dendritic Spikes in CA1 Pyramidal NeuronsJournal of Neuroscience, 2004
- Oscillatory Coupling of Hippocampal Pyramidal Cells and Interneurons in the Behaving RatJournal of Neuroscience, 1999
- Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neuronsBiophysical Journal, 1996
- Synaptic loss in Alzheimer's disease and other dementiasNeurology, 1989
- Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease.1987